Literature DB >> 35794930

A Quality Initiative to Improve Postdischarge Care for Patients on Outpatient Parenteral Antimicrobial Therapy.

Laura K Certain1, Russell J Benefield2, Michael Newman3, Mingyuan Zhang3, Frank O Thomas4.   

Abstract

Background: Patients discharged from the hospital on outpatient parenteral antimicrobial therapy (OPAT) require close monitoring, including weekly blood tests and an early posthospital follow-up visit. However, because patients often receive OPAT in a separate healthcare system from where they received inpatient care, the OPAT plan often fails, with less than 75% of OPAT patients receiving the recommended laboratory monitoring. We sought to determine whether changing our inpatient OPAT documentation method would improve postdischarge care.
Methods: As a quality improvement initiative, we conducted 2 Plan-Do-Study-Act interventions on our OPAT documentation. Our first intervention was to create a standardized OPAT Progress Note, and our second was to turn that note into a SmartForm (Epic) with discrete fields for the key information. We examined the effects of these changes on the rate of completion of recommended laboratory monitoring, attendance at outpatient follow-up visits, and 30-day readmission rates.
Results: Changing our documentation to a standardized Progress Note and then to a SmartForm with discrete fields led to an increase in the proportion of patients with a serum creatinine checked within 10 days of discharge (from 63% to 71% to 73%) and who attended an infectious disease clinic visit within 3 weeks of discharge (from 21% to 36% to 47%). However, the rate of readmissions for OPAT-related problems did not change, nor did a composite outcome of 30-day mortality/unplanned readmission. Conclusions: Changes in how and where care plans are documented in the inpatient medical record can have significant effects on patient care outcomes after discharge.
© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Entities:  

Keywords:  care transitions; medical record documentation; outpatient parenteral antimicrobial therapy (OPAT); quality improvement

Year:  2022        PMID: 35794930      PMCID: PMC9251666          DOI: 10.1093/ofid/ofac199

Source DB:  PubMed          Journal:  Open Forum Infect Dis        ISSN: 2328-8957            Impact factor:   4.423


  19 in total

1.  Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines.

Authors:  Alan D Tice; Susan J Rehm; Joseph R Dalovisio; John S Bradley; Lawrence P Martinelli; Donald R Graham; R Brooks Gainer; Mark J Kunkel; Robert W Yancey; David N Williams
Journal:  Clin Infect Dis       Date:  2004-05-26       Impact factor: 9.079

2.  Study designs for PDSA quality improvement research.

Authors:  Theodore Speroff; Gerald T O'Connor
Journal:  Qual Manag Health Care       Date:  2004 Jan-Mar       Impact factor: 0.926

3.  A Quality Initiative to Improve Postdischarge Care for Patients on Outpatient Parenteral Antimicrobial Therapy.

Authors:  Laura K Certain; Russell J Benefield; Michael Newman; Mingyuan Zhang; Frank O Thomas
Journal:  Open Forum Infect Dis       Date:  2022-04-15       Impact factor: 4.423

4.  Omission of Physical Therapy Recommendations for High-Risk Patients Transitioning From the Hospital to Subacute Care Facilities.

Authors:  Brock Polnaszek; Jacquelyn Mirr; Rachel Roiland; Andrea Gilmore-Bykovskyi; Melissa Hovanes; Amy Kind
Journal:  Arch Phys Med Rehabil       Date:  2015-08-05       Impact factor: 3.966

5.  The consequences of poor communication during transitions from hospital to skilled nursing facility: a qualitative study.

Authors:  Barbara J King; Andrea L Gilmore-Bykovskyi; Rachel A Roiland; Brock E Polnaszek; Barbara J Bowers; Amy J H Kind
Journal:  J Am Geriatr Soc       Date:  2013-06-03       Impact factor: 5.562

6.  Hospital discharge documentation of a designated clinician for follow-up care and 30-day outcomes in hip fracture and stroke patients discharged to sub-acute care.

Authors:  Andrea L Gilmore-Bykovskyi; Korey A Kennelty; Eva DuGoff; Amy J H Kind
Journal:  BMC Health Serv Res       Date:  2018-02-09       Impact factor: 2.655

7.  Which Patients Discharged to Home-Based Outpatient Parenteral Antimicrobial Therapy Are at High Risk of Adverse Outcomes?

Authors:  Sara C Keller; Nae-Yuh Wang; Alejandra Salinas; Deborah Williams; Jennifer Townsend; Sara E Cosgrove
Journal:  Open Forum Infect Dis       Date:  2020-05-20       Impact factor: 3.835

8.  Self-Administered Outpatient Antimicrobial Infusion by Uninsured Patients Discharged from a Safety-Net Hospital: A Propensity-Score-Balanced Retrospective Cohort Study.

Authors:  Kavita P Bhavan; L Steven Brown; Robert W Haley
Journal:  PLoS Med       Date:  2015-12-15       Impact factor: 11.069

9.  Explanation and elaboration of the SQUIRE (Standards for Quality Improvement Reporting Excellence) Guidelines, V.2.0: examples of SQUIRE elements in the healthcare improvement literature.

Authors:  Daisy Goodman; Greg Ogrinc; Louise Davies; G Ross Baker; Jane Barnsteiner; Tina C Foster; Kari Gali; Joanne Hilden; Leora Horwitz; Heather C Kaplan; Jerome Leis; John C Matulis; Susan Michie; Rebecca Miltner; Julia Neily; William A Nelson; Matthew Niedner; Brant Oliver; Lori Rutman; Richard Thomson; Johan Thor
Journal:  BMJ Qual Saf       Date:  2016-04-13       Impact factor: 7.035

10.  Outpatient Parenteral Therapy for Complicated Staphylococcus aureus Infections: A Snapshot of Processes and Outcomes in the Real World.

Authors:  Jennifer Townsend; Sara Keller; Martin Tibuakuu; Sameer Thakker; Bailey Webster; Maya Siegel; Kevin J Psoter; Omar Mansour; Trish M Perl
Journal:  Open Forum Infect Dis       Date:  2018-10-24       Impact factor: 3.835

View more
  1 in total

1.  A Quality Initiative to Improve Postdischarge Care for Patients on Outpatient Parenteral Antimicrobial Therapy.

Authors:  Laura K Certain; Russell J Benefield; Michael Newman; Mingyuan Zhang; Frank O Thomas
Journal:  Open Forum Infect Dis       Date:  2022-04-15       Impact factor: 4.423

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.